Next Article in Journal
Mutational Analysis of Merkel Cell Carcinoma
Next Article in Special Issue
Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder
Previous Article in Journal
From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice
Previous Article in Special Issue
Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues
Open AccessReview

MET and Small-Cell Lung Cancer

1
Medical Oncology Unit 1, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy
2
Operative Unit of Pathology, Azienda Ospedaliero-Universitaria Policlinico, Via del Pozzo 71, 41124 Modena, Italy
3
Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Viale A. Gramsci 14, 43126 Parma, Italy
*
Author to whom correspondence should be addressed.
Cancers 2014, 6(4), 2100-2115; https://doi.org/10.3390/cancers6042100
Received: 6 August 2014 / Revised: 21 September 2014 / Accepted: 22 September 2014 / Published: 13 October 2014
(This article belongs to the Special Issue MET in Cancer)
Small-cell lung cancer (SCLC) is one of the most aggressive lung tumors. The majority of patients with SCLC are diagnosed at an advanced stage. This tumor type is highly sensitive to chemo-radiation treatment, with very high response rates, but invariably relapses. At this time, treatment options are still limited and the prognosis of these patients is poor. A better knowledge of the molecular biology of SCLC allowed us to identify potential druggable targets. Among these, the MET/HGF axis seems to be one of the most aberrant signaling pathways involved in SCLC invasiveness and progression. In this review, we describe briefly all recent literature on the different molecular profiling in SCLC; in particular, we discuss the specific alterations involving c-MET gene and their implications as a potential target in SCLC. View Full-Text
Keywords: c-MET; small-cell lung cancer; mutations; c-MET signaling pathway c-MET; small-cell lung cancer; mutations; c-MET signaling pathway
Show Figures

Figure 1

MDPI and ACS Style

Gelsomino, F.; Rossi, G.; Tiseo, M. MET and Small-Cell Lung Cancer. Cancers 2014, 6, 2100-2115.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop